Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$0.10 USD
0.00 (-4.32%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $0.10 0.00 (-3.94%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Tonix Pharmaceuticals Holding Corp. [TNXP]
Reports for Purchase
Showing records 81 - 100 ( 154 total )
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
TNX-201 Failed. Moving on to PTSD (2Q16), Fibromyalgia (3Q16)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
3Q15 Recap - Tonmya Data Targeted in 3Q16 (from 2H16)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
2Q15 Recap - Tonmya Expedited, and 1H16 Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Updated Model - Phase 3 Fibromyalgia Trial Underway
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: NAPODANO J